![Dolores Schendel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dolores Schendel
Chief Tech/Sci/R&D Officer at
MEDIGENE AG
Profile
Dr. Dolores J.
Schendel is a Chief Scientific Officer at MediGene AG and a Chief Executive Officer at Medigene, Inc. Dr. Schendel was previously employed as a Managing Director by Medigene Immunotherapies GmbH, a Member-Scientific Review Board by Deutsche Forschungsgemeinschaft, a Member-Scientific Review Board by European Research Council, a Member-Scientific Review Board by German Cancer Aid, and a Professor by Ludwig-Maximilians-Universität München.
She also served on the board at Institute of Molecular Immunology.
She received her doctorate degree from the University of Wisconsin.
Dolores Schendel active positions
| Companies | Position | Start |
|---|---|---|
| MEDIGENE AG | Chief Tech/Sci/R&D Officer | 2014-04-30 |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Chief Executive Officer | - |
Former positions of Dolores Schendel
| Companies | Position | End |
|---|---|---|
Institute of Molecular Immunology | Director/Board Member | 2012-12-31 |
European Research Council
 European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Corporate Officer/Principal | - |
German Cancer Aid | Corporate Officer/Principal | - |
Deutsche Forschungsgemeinschaft
 Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Medigene Immunotherapies GmbH
 Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Chief Executive Officer | - |
Training of Dolores Schendel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Miscellaneous |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Molecular Immunology | |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Health Technology |
German Cancer Aid |
- Stock Market
- Insiders
- Dolores Schendel
